|
| Press Releases |
|
 |
|
| Wednesday, September 8, 2021 |
|
|
阿诺医药宣布AN2025、AN0025与atezolizumab三联治疗晚期实体瘤1a期临床在美国完成首例患者给药 |
阿诺医药，一家专注于肿瘤治疗领域的创新型全球生物制药公司，今日宣布其口服泛PI3K抑制剂buparlisib（AN2025）、口服EP4拮抗剂（AN0025）与PD-L1抑制剂atezolizumab（阿替利珠单抗）三联疗法在晚期/转移性实体瘤患者中开展的Ia期临床试验已于美国成功完成首例患者给药。
more info >> |
|
|
阿諾醫藥宣佈AN2025、AN0025與atezolizumab三聯治療晚期實體瘤1a期臨床在美國完成首例患者給藥 |
| 阿諾醫藥，一家專注於腫瘤治療領域的創新型全球生物製藥公司，今日宣佈其口服泛PI3K抑制劑buparlisib（AN2025）、口服EP4拮抗劑（AN0025）與PD-L1抑制劑atezolizumab（阿替利珠單抗）三聯療法在晚期/轉移性實體瘤患者中開展的Ia期臨床試驗已于美國成功完成首例患者給藥。 more info >> |
|
|
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors |
| Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the Phase Ia clinical trial in the U.S. to evaluate the triple combination of AN2025 (buparlisib, oral pan-PI3K inhibitor), AN0025 (oral EP4 antagonist) and atezolizumab (PD-L1 inhibitor) in patients with locally advanced/metastatic tumors. more info >> |
|
| Thursday, July 15, 2021 |
|
|
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures |
| Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
三菱重工機械システム、シンガポールでV2X対応システムの開発と実証試験に成功
Oct 6, 2022 12:00: JST
|
|
|
Apeiron Bioenergy secures equity investment from Proterra Investment Partners Asia to solidify upstream capabilities
Oct 6, 2022 11:34: JST
|
|
|
Honda、「FIT」をマイナーモデルチェンジし発売
Oct 6, 2022 11:30: JST
|
|
|
日立が「CEATEC 2022」に出展
Oct 6, 2022 11:00: JST
|
|
|
Apeiron Bioenergy secures equity investment from Proterra Investment Partners Asia to solidify upstream capabilities
Oct 6, 2022 10:34 HKT/SGT
|
|
|
Hela Apparel Holdings Consolidates Growth with Go-Live on SAP S/4HANA with attune, a Rizing Company
Oct 6, 2022 09:00 HKT/SGT
|
|
|
Hela Apparel Holdings Consolidates Growth with Go-Live on SAP S/4HANA with attune, a Rizing Company
Oct 6, 2022 09:00 HKT/SGT
|
|
|
MRHB and Gold & Silver Standard (GSS) Partner to Expand Halal DeFi Offerings with Tokenized Precious Metals
Oct 5, 2022 23:00: JST
|
|
|
MRHB and Gold & Silver Standard (GSS) Partner to Expand Halal DeFi Offerings with Tokenized Precious Metals
Oct 5, 2022 23:00 HKT/SGT
|
|
|
MMPRO、Gate.ioと共同で、NFTをスタートアップパネルツールとして利用するユニークな方法を実施
Oct 5, 2022 23:00: JST
|
|
|
MMPRO、Gate.ioと共同で、NFTをスタートアップパネルツールとして利用するユニークな方法を実施
Oct 5, 2022 23:00: JST
|
|
|
艾美疫苗公布全球发售结果 每股H股发售股份发售价为16.16港元
Oct 5, 2022 18:57 HKT/SGT
|
|
|
艾美疫苗公佈全球發售結果 每股H股發售股份發售價為16.16港元
Oct 5, 2022 18:56 HKT/SGT
|
|
|
AIM Vaccine Announces Global Offering Results, Offer Price of HK$16.16 per H Share
Oct 5, 2022 18:55 HKT/SGT
|
|
|
多宁生物拟赴港上市：先发优势显著 业绩增长强劲
Oct 5, 2022 18:46 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
